Evaluate the Safety and Tolerability of a Single-dose Administration of BMI2004 Inj.
NCT05922813
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
257
Enrollment
INDUSTRY
Sponsor class
Conditions
Health, Subjective
Interventions
BIOLOGICAL:
BMI2004
OTHER:
0.9% NaCl
Sponsor
BMI Korea